Circadian rhythms and metabolic syndrome: from experimental genetics to human disease.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and clinical literature without systematic search methodology
PubMed 20167942 · doi:10.1161/CIRCRESAHA.109.208355
What was done
This narrative review synthesized findings from experimental genetics and clinical medicine examining the role of circadian system alterations and sleep disruption in the pathogenesis of metabolic syndrome and related disorders.
What was found
The abstract reports no numerical findings or quantitative statistics. It summarizes narrative connections between internal clock perturbations, sleep alterations, and risk factors including obesity, diabetes mellitus, cardiovascular disease, thrombosis, and inflammation.
Why it matters
The review outlines how circadian biology interacts with metabolic regulation, highlighting potential opportunities for mechanism-based therapeutics.
Limits
As a narrative review, it lacks a systematic search protocol, quality appraisal, or meta-analytic data. No specific sample sizes, effect sizes, or trial details are reported in the abstract.
Cited by
- supports Mice lacking a functional circadian clock due to gene mutations or knockouts develop obesity, diabetes, and cardiovascular diseases.